These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35493453)
21. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation. Kanda Y; Oshima K; Kako S; Fukuda T; Uchida N; Miyamura K; Kondo Y; Nakao S; Nagafuji K; Miyamoto T; Kurokawa M; Okoshi Y; Chiba S; Ohashi Y; Takaue Y; Taniguchi S Am J Hematol; 2013 Apr; 88(4):294-300. PubMed ID: 23450467 [TBL] [Abstract][Full Text] [Related]
22. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide. Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S Ann Hematol; 2021 May; 100(5):1295-1301. PubMed ID: 33580280 [TBL] [Abstract][Full Text] [Related]
23. Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells. Yu J; Ren X; Yan F; Li H; Cao S; Chen Y; Sun H; An X; Zhang N; Hao X Transpl Int; 2011 Feb; 24(2):201-12. PubMed ID: 21062369 [TBL] [Abstract][Full Text] [Related]
24. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts. Arcuri LJ; Hamerschlak N; Rocha V; Bonfim C; Kerbauy MN Transplant Cell Ther; 2021 Sep; 27(9):782.e1-782.e7. PubMed ID: 34146733 [TBL] [Abstract][Full Text] [Related]
26. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia. How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457 [TBL] [Abstract][Full Text] [Related]
27. Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study. Uygun V; Karasu G; Daloğlu H; Öztürkmen S; Çakı Kılıç S; Hazar V; Yeşilipek A Pediatr Transplant; 2019 Nov; 23(7):e13546. PubMed ID: 31278838 [TBL] [Abstract][Full Text] [Related]
28. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease. Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314 [TBL] [Abstract][Full Text] [Related]
29. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Luznik L; O'Donnell PV; Fuchs EJ Semin Oncol; 2012 Dec; 39(6):683-93. PubMed ID: 23206845 [TBL] [Abstract][Full Text] [Related]
30. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease. Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439 [TBL] [Abstract][Full Text] [Related]
31. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis. Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648 [TBL] [Abstract][Full Text] [Related]
32. High plasma IL-6 levels following haploidentical allogeneic hematopoietic stem cell transplantation post-transplant cyclophosphamide as predictor of early death and worse outcome. Farias MG; de Mello Vicente B; Habigzang M; Hirakata VN; de Oliveira da Silva P; Paz AA; Daudt LE Transpl Immunol; 2022 Apr; 71():101543. PubMed ID: 35093504 [TBL] [Abstract][Full Text] [Related]
33. Increased Infections and Delayed CD4 Khimani F; Ranspach P; Elmariah H; Kim J; Whiting J; Nishihori T; Locke FL; Perez Perez A; Dean E; Mishra A; Perez L; Lazaryan A; Jain MD; Nieder M; Liu H; Faramand R; Hansen D; Alsina M; Ochoa L; Davila M; Anasetti C; Pidala J; Bejanyan N Transplant Cell Ther; 2021 Nov; 27(11):940-948. PubMed ID: 34329754 [TBL] [Abstract][Full Text] [Related]
34. Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation. El-Cheikh J; Devillier R; Dulery R; Massoud R; Al Chami F; Ghaoui N; Moukalled N; Pagliardini T; Marino F; Malard F; Bazarbachi AH; Mohty R; Bazarbachi A; Castagna L; Mohty M; Blaise D Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):617-623. PubMed ID: 32457025 [TBL] [Abstract][Full Text] [Related]
35. Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease. Al-Homsi AS; Roy TS; Cole K; Feng Y; Duffner U Biol Blood Marrow Transplant; 2015 Apr; 21(4):604-11. PubMed ID: 25240817 [TBL] [Abstract][Full Text] [Related]
36. Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin Inhibitors. Solh MM; Baron J; Zhang X; Bashey A; Morris LE; Holland HK; Solomon SR Biol Blood Marrow Transplant; 2020 Nov; 26(11):2082-2088. PubMed ID: 32745575 [TBL] [Abstract][Full Text] [Related]
37. Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas. Montes de Oca C; Castagna L; De Philippis C; Bramanti S; Schiano JM; Pagliardini T; Collignon A; Harbi S; Mariotti J; Granata A; Maisano V; Furst S; Legrand F; Chabannon C; Carlo-Stella C; Santoro A; Blaise D; Devillier R Biol Blood Marrow Transplant; 2020 Dec; 26(12):2299-2305. PubMed ID: 32822845 [TBL] [Abstract][Full Text] [Related]
38. [Selective elimination of alloreactive donor lymphocytes by using TBI and cyclophosphamide]. Chen BA; Dong WM; Ding JH; Sun XM; Deng XJ; Zhang Y; Bi YZ; Zhao G; Gao C; Sun YY; Wang J; Cheng J; Schmitt M; Schmitt A Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):332-6. PubMed ID: 17493342 [TBL] [Abstract][Full Text] [Related]
39. Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation. Baumeister SHC; Rambaldi B; Shapiro RM; Romee R Front Immunol; 2020; 11():191. PubMed ID: 32117310 [TBL] [Abstract][Full Text] [Related]